Wendy Douglass

730 total citations
12 papers, 493 citations indexed

About

Wendy Douglass is a scholar working on Hematology, Immunology and Rheumatology. According to data from OpenAlex, Wendy Douglass has authored 12 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 6 papers in Immunology and 4 papers in Rheumatology. Recurrent topics in Wendy Douglass's work include Autoimmune and Inflammatory Disorders Research (5 papers), Cell Adhesion Molecules Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Wendy Douglass is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), Cell Adhesion Molecules Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Wendy Douglass collaborates with scholars based in United Kingdom, United States and Argentina. Wendy Douglass's co-authors include Kevin Latinis, Bernard Combe, Atul Deodhar, Helen E.J. Tyrrell, Artur Racewicz, S.K. Alex Law, G. Armstrong, William F. C. Rigby, Carlos Abud‐Mendoza and John D. Isaacs and has published in prestigious journals such as The Journal of Immunology, FEBS Letters and Annals of the Rheumatic Diseases.

In The Last Decade

Wendy Douglass

12 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Douglass United Kingdom 9 246 166 140 99 90 12 493
Gudrun Reynisdottir Sweden 6 347 1.4× 114 0.7× 52 0.4× 33 0.3× 29 0.3× 12 563
Irene Smolik Canada 14 495 2.0× 140 0.8× 78 0.6× 26 0.3× 57 0.6× 28 692
M. Safy Netherlands 7 240 1.0× 149 0.9× 64 0.5× 21 0.2× 49 0.5× 10 375
GR Burmester Germany 10 310 1.3× 248 1.5× 49 0.3× 24 0.2× 35 0.4× 28 495
Haraldine A. Stafford United States 12 305 1.2× 327 2.0× 117 0.8× 21 0.2× 63 0.7× 22 578
G Szegedi Hungary 14 259 1.1× 344 2.1× 86 0.6× 22 0.2× 58 0.6× 73 624
Trieneke C. G. Timmer Netherlands 6 254 1.0× 174 1.0× 41 0.3× 24 0.2× 31 0.3× 8 442
Clarissa E. Vergunst Netherlands 10 290 1.2× 299 1.8× 101 0.7× 43 0.4× 52 0.6× 18 735
Linda Mathsson‐Alm Sweden 14 369 1.5× 145 0.9× 39 0.3× 33 0.3× 26 0.3× 28 493
Samy Metyas United States 6 289 1.2× 344 2.1× 37 0.3× 19 0.2× 40 0.4× 6 492

Countries citing papers authored by Wendy Douglass

Since Specialization
Citations

This map shows the geographic impact of Wendy Douglass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Douglass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Douglass more than expected).

Fields of papers citing papers by Wendy Douglass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Douglass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Douglass. The network helps show where Wendy Douglass may publish in the future.

Co-authorship network of co-authors of Wendy Douglass

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Douglass. A scholar is included among the top collaborators of Wendy Douglass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Douglass. Wendy Douglass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Malattia, Clara, Nicolino Ruperto, Silvia Pederzoli, et al.. (2020). Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials. Arthritis Research & Therapy. 22(1). 211–211. 12 indexed citations
2.
Hsu, Joy, Wendy Douglass, Chris Wells, et al.. (2019). Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. Pediatric Rheumatology. 17(1). 57–57. 19 indexed citations
3.
Benedetti, Fabrizio De, Nicolino Ruperto, Athimalaipet V Ramanan, et al.. (2019). THU0516 LONG-TERM SAFETY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTRATION IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 78. 548–548. 3 indexed citations
4.
Fettner, Scott, et al.. (2019). Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. Expert Opinion on Drug Delivery. 16(5). 551–561. 12 indexed citations
5.
Cuttica, R, Hans‐Iko Huppertz, Rik Joos, et al.. (2018). THU0598 Safety of tocilizumab in patients aged <2 years with active systemic juvenile idiopathic arthritis treated for one year. Annals of the Rheumatic Diseases. 77. 499–499. 1 indexed citations
6.
Abdallah, Hisham, Joy Hsu, Peng Lü, et al.. (2016). Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA. The Journal of Clinical Pharmacology. 57(4). 459–468. 70 indexed citations
7.
8.
Hyland, Robert H., Wendy Douglass, Suet‐Mien Tan, & S.K. Alex Law. (2001). Chimeras of the Integrin β Subunit Mid-Region Reveal Regions Required for Heterodimer Formation and for Activation. Cell Communication & Adhesion. 8(2). 61–69. 5 indexed citations
9.
Tan, Suet‐Mien, Robert H. Hyland, Aymen Al‐Shamkhani, et al.. (2000). Effect of Integrin β2 Subunit Truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) Assembly, Surface Expression, and Function. The Journal of Immunology. 165(5). 2574–2581. 53 indexed citations
10.
Douglass, Wendy, Robert H. Hyland, Christopher D. Buckley, et al.. (1998). The role of the cysteine‐rich region of the β2 integrin subunit in the leukocyte function‐associated antigen‐1 (LFA‐1, αLβ2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Letters. 440(3). 414–418. 25 indexed citations
11.
Douglass, Wendy, G M Taylor, YL Lau, et al.. (1995). Molecular characterization of leukocyte adhesion deficiency in six patients. European Journal of Immunology. 25(3). 717–722. 32 indexed citations
12.
Stevenson, Freda K., Wendy Douglass, Myfanwy B. Spellerberg, Marie Walters, & M I Cawley. (1990). Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis. Clinical & Experimental Immunology. 80(1). 32–37. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gudrun Reynisdottir Breakdown of academic impact, for papers by Irene Smolik Breakdown of academic impact, for papers by M. Safy Breakdown of academic impact, for papers by GR Burmester Breakdown of academic impact, for papers by Haraldine A. Stafford Breakdown of academic impact, for papers by G Szegedi Breakdown of academic impact, for papers by Trieneke C. G. Timmer Breakdown of academic impact, for papers by Clarissa E. Vergunst Breakdown of academic impact, for papers by Linda Mathsson‐Alm Breakdown of academic impact, for papers by Samy Metyas
Rankless by CCL
2026